<table id="s8bqp"><p id="s8bqp"></p></table>
        1. <tt id="s8bqp"></tt>
          About Kingfriend
          Kingfriend Overview

          Nanjing Kingfriend integrates drug research and development, production and sales.

          Listed on SSE A share on 19th July, 2017, Kingfriend has, not only the world’s leading isolator production line and advanced aseptic injection production technology, but also a globalized quality system, approved by many countries and regions, including China, the United States, Europe, Japan and Brazil, etc. With a world-class production research and development speed and the globalized quality awareness, we have the sales capability that make us take root in the U.S. market. Besides, injectable CDMO service, covering the global market while targeting at China and US markets’, can be provided by us. By attracting and recruiting talents from all over the globe, our newly established bio-innovative pharmaceuticals business department aims at becoming an innovative and international biopharmaceutical company that is superior in pharmaceutical field.
          • 50+
          • 10+
          • 3times
          • 10+
          • 10+
          Total ANDA approvals
          New ANDA approvals obtained each year
          FDA-compliant high-speed isolator production line
          Annual declaration of products to FDA
          Cumulative number of FDA inspection passed
          The Global Industry Layout

          We establish efficient, integrated and open project management systems for global pharmaceutical companies

          • Nanjing Headquarter

            R&D Center
            Development, production and commercial manufacturing of small molecule injectables
            Drug development and commercialization based on mRNA technology
            Treatment based on nucleic acid detection technology (mRNA)
            Bioinformatics determination of target molecules
            platform for mRNA in vitro synthesis and modification
            Drug delivery system development
          • Cheng Du

            R&D center
            Hydro-acupuncture and lyophilization product line
            Monoclonal antibody-based drugs (mAb)
            Early research and development of monoclonal antibody
            Commercial development monoclonal antibodies
          • Chicago, USA

            Global Clinical Research Center
            U.S. Marketing
          Milestones

          Over the past 30 years, we have been refreshing our goals and making positive progress.

          2022
          57 ANDA approvals obtained in total
          pipeline expansion at a rate of 10 new projects per year
          2021
          Establishment of Bio-innovative Business Department
          Improved R&D capabilities and entered the field of biologics
          2019
          Acquisition of US pharmaceutical company Meitheal
          Broadened the global market of preparations and completed the coverage of the industry chain
          2016
          Acquisition of Chengdu Jianjin Pharmaceutical
          Full set of FDA-compliant GMP workshop
          audited by the FDA
          2014
          Passed CFDA GMP inspection
          Obtained three domestic approvals and started filling with ANDA
          2011
          Construction of Nanjing FDF plant started
          The world’s top FDF plant
          2004
          Launch of enoxaparin, nadroparin and dalteparin preparation projects
          Initiated the development and declaration of heparin-based APIs and preparations
          2000
          Establishment of Nanjing Kingfriend Biochemical Pharmaceutical Co, Ltd
          Ventured into pharmaceutical export business
          1991
          Establishment of Nanjing Kingfriend Chemical Biopharmaceutical Factory
          Rapid development in heparin industry
          1987
          Involvement in the field of heparin sodium
          Pioneer in the heparin industry in China
          2022
          2021
          2019
          2016
          2014
          2011
          2004
          2000
          1991
          1987
          Enterprise Honors

          Our employees, who are enterprising and innovative, have obtained a number of remarkable achievements.

          • Awarded the title of Nanjing Outstanding Private Enterprise and Entrepreneur
            2018
            Awarded the title of Nanjing Outstanding Private Enterprise and Entrepreneur
          • Nanjing Municipal Key Leading Enterprise of Agricultural Industrialization
            2022
            Nanjing Municipal Key Leading Enterprise of Agricultural Industrialization
          • Outstanding Company of Open Economy of Jiangsu Province
            2012
            Outstanding Company of Open Economy of Jiangsu Province
          • Enterprise Technology Center recognized by Jiangsu Province
            2022
            Enterprise Technology Center recognized by Jiangsu Province
          • Enterprise Technology Center recognized by Jiangsu Province
            2014
            Enterprise Technology Center recognized by Jiangsu Province
          • National-level High-tech Enterprise Certificate
            2018
            National-level High-tech Enterprise Certificate
          • Awarded the title of Nanjing Smart Factory
            2015
            Awarded the title of Nanjing Smart Factory
          • Private Technology Enterprise Certificate
            2017
            Private Technology Enterprise Certificate
          More honors
          在线日韩日本国产亚洲_国产成人免费视频一区二区三区_国产一级做a爱片久久毛片A_久久婷婷大香萑太香蕉av

              <table id="s8bqp"><p id="s8bqp"></p></table>
                1. <tt id="s8bqp"></tt>